Skip to main content
Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
18.67
+2.93 (18.62%)
Dec 20, 2024, 4:00 PM EST - Market closed

Exicure Revenue

Exicure had revenue of $500.00K in the twelve months ending September 30, 2024, down -97.70% year-over-year.

Revenue (ttm)
$500.00K
Revenue Growth
-97.70%
P/S Ratio
68.12
Revenue / Employee
$83,333
Employees
6
Market Cap
48.65M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 202228.83M29.31M-6,068.12%
Dec 31, 2021-483.00K-17.10M-102.91%
Dec 31, 202016.61M15.32M1,181.87%
Dec 31, 20191.30M1.18M998.31%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xtant Medical Holdings 113.86M
Fortress Biotech 81.50M
SHL Telemedicine 55.94M
Cytosorbents 37.74M
iCAD, Inc. 18.94M
Singular Genomics Systems 2.67M
vTv Therapeutics 1.00M
Inovio Pharmaceuticals 203.41K
Revenue Rankings

XCUR News

More News